These findings align with the established patterns of response across intrinsic subtypes: luminal A and luminal B/HER2-negative tumours, characterised by strong hormone receptor expression and relatively low proliferation, frequently show incomplete nodal response to NACT and may harbour residual micrometastatic disease despite modest radiologic changes [27,28,29,30,31]. This evidence concerns the gene ERBB2 and neoplasm.